Show simple item record

dc.contributor.authorFroud, J.
dc.contributor.authorHaslam, Colin
dc.contributor.authorJohal, Sukhdev
dc.contributor.authorWilliams, Karel
dc.contributor.authorWillis, Robert
dc.identifier.citationFroud , J , Haslam , C , Johal , S , Williams , K & Willis , R 1998 , ' British pharmaceuticals : a cautionary tale ' , Economy and Society , vol. 27 , no. 4 , pp. 554-584 .
dc.identifier.otherPURE: 532016
dc.identifier.otherPURE UUID: 8fcd99ff-5d3d-4a54-9267-23b61cd40acc
dc.identifier.otherScopus: 0032432189
dc.descriptionCopyright 2004 Elsevier Science B.V., Amsterdam. All rights reserved.
dc.description.abstractBritish pharmaceuticals is generally represented as a successful sector which illustrates the potential of knowledge-intensive, high-value-added activities. this article presents a revisionist account based on evidence and argument. Pharmaceuticals is a small sector which combines high-value-added and average wages to benefit capital not labour. the knowledgebase in the laboratory creates imitative product with marketing then applied to capture social expenditure. when product-market growth slows, the sector restructures defensively without solving its problems.en
dc.relation.ispartofEconomy and Society
dc.titleBritish pharmaceuticals : a cautionary taleen
dc.contributor.institutionDepartment of Accounting, Finance and Economics
dc.contributor.institutionSocial Sciences, Arts & Humanities Research Institute
dc.description.statusPeer reviewed
rioxxterms.typeJournal Article/Review

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record